eDruginfo.com
Wolters Kluwer | Lippencott Williams & Wilkins
Drug Updates | New Indications

   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

   News Capsules

   Drug Warnings

   Herbal Spotlight

   Quik Tools

   Drug Info Links

   Drug Info Bookstore

   Feedback

   Registration

   Disclaimer



topotecan
Hycamtin Pharmaceutical company:
GlaxoSmithKline
www.gsk.com

NEW INDICATION & DOSAGE
Relapsed small-cell lung cancer in patients who have had a complete or partial response to first-line chemotherapy--
Adults: 2.3 mg/m2/day P.O. once daily for 5 consecutive days; repeat cycle every 21 days. Swallow whole, don't cut, crush, or chew.
ADJUST-A-DOSE:
If bone marrow suppression occurs, reduce drug dosage or stop drug depending on level of suppression.

     
   

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our
Disclaimer .

© Copyright 2008 by Lippincott Williams & Wilkins